Clinical Trial Update: A Phase 3 Clinical Study of KW-3357 in Patients With DIC [Phase 3]

View source ↗

Summary

A Phase 3 trial of KW-3357 for disseminated intravascular coagulation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disseminated Intravascular Coagulation

Drugs mentioned

• KW-3357

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Disseminated Intravascular Coagulation (DIC) | Phase 3 | Status: TERMINATED